Group 1 - The stock of Meihao Medical (301363) closed at 24.6 yuan on September 3, 2025, down 1.4% with a turnover rate of 9.95% and a trading volume of 155,500 hands, resulting in a transaction amount of 387 million yuan [1] - On September 3, 2025, the net inflow of main funds was 23.1 million yuan, accounting for 5.97% of the total transaction amount, while retail investors had a net outflow of 27.2 million yuan, accounting for 7.03% [1] - Over the past five days, the stock has experienced fluctuations in both main and retail fund flows, with notable changes in net inflows and outflows [1] Group 2 - Meihao Medical's total market value is 13.994 billion yuan, which is higher than the industry average of 11.994 billion yuan, ranking 24th out of 123 in the medical device industry [2] - The company's net profit for the first half of 2025 was 114 million yuan, a decrease of 32.44% year-on-year, while its main revenue was 733 million yuan, an increase of 3.73% year-on-year [2] - The company reported a gross profit margin of 37.52%, which is significantly lower than the industry average of 51.85%, ranking 93rd out of 123 [2] Group 3 - In the last 90 days, 16 institutions have rated the stock, with 14 buy ratings and 2 hold ratings, and the average target price set by institutions is 26.48 yuan [3]
股票行情快报：美好医疗（301363）9月3日主力资金净买入2309.63万元